Table 2.
Stakeholders and Quality Assurance Throughout the Cold Chain.
![]() | ||||
---|---|---|---|---|
Manufacturer | Distributor/wholesaler | Pharmacy/hospital | People with diabetes | |
Guidelines | Good Distribution Guidelines by WHO, European Commission, US Pharmacopeia, etc. |
Limited, inconsistent information in guidelines by health organizations | ||
National law for pharmacies/hospitals | ||||
Other quality systems | Quality system by manufacturer Contracts with distributors |
Quality system by institution | ||
Available information | Knowledge of stability data | Package leaflet, might know stability data | Package leaflet, professional training | Package leaflet, education from HCPs, product website |
Quality assurance measures | - Liability of manufacturer, responsibility to recall products - Risk assessment based on recorded temperature data - Audits, quality control - Training of staff - Use of validated materials (medical refrigerators, tested shipping boxes, refrigerated transporters, etc.) - Temperature monitoring - Documentation |
- No quality control - No risk assessment possible - Suboptimal storage in home refrigerator - Use of cool bags |
Abbreviation: HCPs, health care professionals.